Express Scripts' $29B Medco Buy To Face Antitrust Test
Express Scripts Inc. revealed plans Thursday to acquire rival pharmacy benefit manager Medco Health Solutions Inc. in a $29.1 billion cash-and-stock deal that experts say is likely to draw significant antitrust...To view the full article, register now.
Already a subscriber? Click here to view full article